Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jul 14, 2017 at 11:40 AM EDT

Apollo Endosurgery Gears Up for Secondary Offering

Medical technology company Apollo Endosurgery saw its shares slide on Friday after the company announced terms of its secondary offering.

Chris Lange | Jul 13, 2017 at 9:40 AM EDT

Short Sellers Hike Bets in Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jul 13, 2017 at 9:20 AM EDT

Major Pharma Short Sellers Become More Selective

The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jul 12, 2017 at 10:25 AM EDT

Why Ocular Therapeutix Shares Are Getting Crushed

Ocular Therapeutix shares were absolutely crushed on Wednesday after the company received less than favorable news from the FDA regarding…

Chris Lange | Jul 11, 2017 at 1:20 PM EDT

PetIQ Announces Potential Pricing for IPO

PetIQ intends to price more than 5 million shares in the range of $14 to $16 apiece in an initial…

Chris Lange | Jul 11, 2017 at 12:10 PM EDT

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's…

Chris Lange | Jul 11, 2017 at 10:50 AM EDT

Why Arena Pharmaceuticals Is Knocking It Out of the Park

Shares of Arena Pharmaceuticals saw an incredible gain early Tuesday after the company reported positive results from its mid-stage trial…

Lee Jackson | Jul 11, 2017 at 10:10 AM EDT

3 Red-Hot Medical Tech Stocks That Could Beat Earnings Estimates

Despite the concerns over the struggles of politicians to craft a new health care plan for the United States, the…

Chris Lange | Jul 10, 2017 at 10:25 AM EDT

Kala Pharmaceuticals Gears Up for IPO

Kala Pharmaceuticals intends to price 6 million shares in the range of $14 to $16 apiece in an initial public…

Chris Lange | Jul 7, 2017 at 1:00 PM EDT

FDA Issues an Approval Not Seen in Almost 20 Years

In an incredible move on Friday, the FDA approved Endari for the treatment of patients age five and older with…

Chris Lange | Jul 7, 2017 at 8:50 AM EDT

Why Conatus Pharma Wins With Newest Licensing Agreement

Conatus Pharmaceuticals saw its shares make a handy gain on Friday after the firm announced an exclusive license agreement with…

Chris Lange | Jul 6, 2017 at 8:35 AM EDT

How Transformative Is This Licensing Deal for BeiGene?

This partnership should be fairly transformative for BeiGene, seeing as it can start making some actual money.

Chris Lange | Jul 5, 2017 at 11:45 AM EDT

Athenex Wins Big on Chinese Cancer Drug

Athenex led biotech stocks higher on Wednesday after its Chinese subsidiary submitted an Investigational New Drug application to the China…

Chris Lange | Jul 5, 2017 at 9:50 AM EDT

Array BioPharma’s New FDA Submissions Enough to Excite Investors?

Array BioPharma has announced the submission to the FDA of two New Drug Applications to support the use of the…

Chris Lange | Jul 1, 2017 at 8:25 AM EDT

Top Stocks to Look For on July’s FDA Calendar

24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of July and…

1 … 161 162 163 164 165 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Apollo Endosurgery Gears Up for Secondary Offering

Short Sellers Hike Bets in Major Biotechs

Major Pharma Short Sellers Become More Selective

Why Ocular Therapeutix Shares Are Getting Crushed

PetIQ Announces Potential Pricing for IPO

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

Why Arena Pharmaceuticals Is Knocking It Out of the Park

3 Red-Hot Medical Tech Stocks That Could Beat Earnings Estimates

Kala Pharmaceuticals Gears Up for IPO

FDA Issues an Approval Not Seen in Almost 20 Years

Why Conatus Pharma Wins With Newest Licensing Agreement

How Transformative Is This Licensing Deal for BeiGene?

Athenex Wins Big on Chinese Cancer Drug

Array BioPharma’s New FDA Submissions Enough to Excite Investors?

Top Stocks to Look For on July’s FDA Calendar

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

5 Medicare Surprises That Catch Retirees Off Guard After 65

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

A 2024 Asset Sale Could Spike Your 2026 Medicare Premium by Hundreds a Month

Clark Howard Praised a Listener Who Built a $1.3 Million Roth and the Reason Has Nothing to Do With Income Tax

5 Medicare Surprises That Catch Retirees Off Guard After 65

Clark Howard Praised a Listener Who Built a $1.3 Million Roth and the Reason Has Nothing to Do With Income Tax

5 Medicare Surprises That Catch Retirees Off Guard After 65

Health and Healthcare Articles

All Health and Healthcare Articles

Apollo Endosurgery Gears Up for Secondary Offering

Short Sellers Hike Bets in Major Biotechs

Major Pharma Short Sellers Become More Selective

Why Ocular Therapeutix Shares Are Getting Crushed

PetIQ Announces Potential Pricing for IPO

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

Why Arena Pharmaceuticals Is Knocking It Out of the Park

3 Red-Hot Medical Tech Stocks That Could Beat Earnings Estimates

Kala Pharmaceuticals Gears Up for IPO

FDA Issues an Approval Not Seen in Almost 20 Years

Why Conatus Pharma Wins With Newest Licensing Agreement

How Transformative Is This Licensing Deal for BeiGene?

Athenex Wins Big on Chinese Cancer Drug

Array BioPharma’s New FDA Submissions Enough to Excite Investors?

Top Stocks to Look For on July’s FDA Calendar

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

5 Medicare Surprises That Catch Retirees Off Guard After 65

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

A 2024 Asset Sale Could Spike Your 2026 Medicare Premium by Hundreds a Month

Featured Reads

Clark Howard Praised a Listener Who Built a $1.3 Million Roth and the Reason Has Nothing to Do With Income Tax

5 Medicare Surprises That Catch Retirees Off Guard After 65